SHELLY LEVINSTEIN: Open Payments
NPI 1023348950 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 37 payments from 15 companies in 2025. Trend: 2023 $479 · 2024 $619 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 13 | $232 |
| AKEBIA THERAPEUTICS INC | 3 | $167 |
| Calliditas Therapeutics US Inc. | 2 | $67 |
| Travere Therapeutics, Inc. | 5 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $41 |
| OPKO Pharmaceuticals, LLC | 2 | $41 |
| KYOWA KIRIN, INC. | 1 | $28 |
| Apellis Pharmaceuticals, Inc. | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
Products named: Vafseo, XPHOZAH 30 MG, IBSRELA, TARPEYO, Kerendia, RAYALDEE, CRYSVITA, Empaveli.
Industry payments across PA — which companies pay providers there.
